BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 28167285)

  • 1. Nanoparticular delivery system for a secretoneurin derivative induces angiogenesis in a hind limb ischemia model.
    Albrecht-Schgoer K; Barthelmes J; Schgoer W; Theurl M; Nardin I; Lener D; Gutmann C; Dünnhaupt S; Bernkop-Schnürch A; Kirchmair R
    J Control Release; 2017 Mar; 250():1-8. PubMed ID: 28167285
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene therapy with the angiogenic cytokine secretoneurin induces therapeutic angiogenesis by a nitric oxide-dependent mechanism.
    Schgoer W; Theurl M; Jeschke J; Beer AG; Albrecht K; Gander R; Rong S; Vasiljevic D; Egger M; Wolf AM; Frauscher S; Koller B; Tancevski I; Patsch JR; Schratzberger P; Piza-Katzer H; Ritsch A; Bahlmann FH; Fischer-Colbrie R; Wolf D; Kirchmair R
    Circ Res; 2009 Nov; 105(10):994-1002. PubMed ID: 19797703
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuropeptide Y
    Eshun D; Saraf R; Bae S; Jeganathan J; Mahmood F; Dilmen S; Ke Q; Lee D; Kang PM; Matyal R
    J Appl Physiol (1985); 2017 Jun; 122(6):1388-1397. PubMed ID: 28302707
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endothelial cell surface vimentin binding peptide induces angiogenesis under hypoxic/ischemic conditions.
    Glaser-Gabay L; Raiter A; Battler A; Hardy B
    Microvasc Res; 2011 Nov; 82(3):221-6. PubMed ID: 21803052
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Secretoneurin gene therapy improves hind limb and cardiac ischaemia in Apo E⁻/⁻ mice without influencing systemic atherosclerosis.
    Theurl M; Schgoer W; Albrecht-Schgoer K; Lener D; Wolf D; Wolf M; Demetz E; Tymoszuk P; Tancevski I; Fischer-Colbrie R; Franz WM; Marschang P; Kirchmair R
    Cardiovasc Res; 2015 Jan; 105(1):96-106. PubMed ID: 25377726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The angiogenic factor secretoneurin induces coronary angiogenesis in a model of myocardial infarction by stimulation of vascular endothelial growth factor signaling in endothelial cells.
    Albrecht-Schgoer K; Schgoer W; Holfeld J; Theurl M; Wiedemann D; Steger C; Gupta R; Semsroth S; Fischer-Colbrie R; Beer AG; Stanzl U; Huber E; Misener S; Dejaco D; Kishore R; Pachinger O; Grimm M; Bonaros N; Kirchmair R
    Circulation; 2012 Nov; 126(21):2491-501. PubMed ID: 23081990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The neuropeptide secretoneurin acts as a direct angiogenic cytokine in vitro and in vivo.
    Kirchmair R; Gander R; Egger M; Hanley A; Silver M; Ritsch A; Murayama T; Kaneider N; Sturm W; Kearny M; Fischer-Colbrie R; Kircher B; Gaenzer H; Wiedermann CJ; Ropper AH; Losordo DW; Patsch JR; Schratzberger P
    Circulation; 2004 Feb; 109(6):777-83. PubMed ID: 14970115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nanoparticle-mediated endothelial cell-selective delivery of pitavastatin induces functional collateral arteries (therapeutic arteriogenesis) in a rabbit model of chronic hind limb ischemia.
    Oda S; Nagahama R; Nakano K; Matoba T; Kubo M; Sunagawa K; Tominaga R; Egashira K
    J Vasc Surg; 2010 Aug; 52(2):412-20. PubMed ID: 20573471
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic angiogenesis of mouse hind limb ischemia by novel peptide activating GRP78 receptor on endothelial cells.
    Hardy B; Battler A; Weiss C; Kudasi O; Raiter A
    Biochem Pharmacol; 2008 Feb; 75(4):891-9. PubMed ID: 18022603
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel model of chronic limb ischemia to therapeutically evaluate the angiogenic effects of drug candidates.
    Shimatani K; Sato H; Saito A; Sasai M; Watanabe K; Mizukami K; Kamohara M; Miyagawa S; Sawa Y
    Am J Physiol Heart Circ Physiol; 2021 Mar; 320(3):H1124-H1135. PubMed ID: 33481698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic neovascularization by nanotechnology-mediated cell-selective delivery of pitavastatin into the vascular endothelium.
    Kubo M; Egashira K; Inoue T; Koga J; Oda S; Chen L; Nakano K; Matoba T; Kawashima Y; Hara K; Tsujimoto H; Sueishi K; Tominaga R; Sunagawa K
    Arterioscler Thromb Vasc Biol; 2009 Jun; 29(6):796-801. PubMed ID: 19325146
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Neuropeptide Secretoneurin Exerts a Direct Effect on Arteriogenesis In Vivo and In Vitro.
    Liu W; Wang F; Zhao M; Fan Y; Cai W; Luo M
    Anat Rec (Hoboken); 2018 Nov; 301(11):1917-1927. PubMed ID: 30288932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cilostazol improves high glucose-induced impaired angiogenesis in human endothelial progenitor cells and vascular endothelial cells as well as enhances vasculoangiogenesis in hyperglycemic mice mediated by the adenosine monophosphate-activated protein kinase pathway.
    Tseng SY; Chao TH; Li YH; Liu PY; Lee CH; Cho CL; Wu HL; Chen JH
    J Vasc Surg; 2016 Apr; 63(4):1051-62.e3. PubMed ID: 25595409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Infiltration of plasma rich in growth factors enhances in vivo angiogenesis and improves reperfusion and tissue remodeling after severe hind limb ischemia.
    Anitua E; Pelacho B; Prado R; Aguirre JJ; Sánchez M; Padilla S; Aranguren XL; Abizanda G; Collantes M; Hernandez M; Perez-Ruiz A; Peñuelas I; Orive G; Prosper F
    J Control Release; 2015 Mar; 202():31-9. PubMed ID: 25626084
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estradiol-induced, endothelial progenitor cell-mediated neovascularization in male mice with hind-limb ischemia.
    Ruifrok WP; de Boer RA; Iwakura A; Silver M; Kusano K; Tio RA; Losordo DW
    Vasc Med; 2009 Feb; 14(1):29-36. PubMed ID: 19144777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. (2-Hydroxypropyl)-β-Cyclodextrin Is a New Angiogenic Molecule for Therapeutic Angiogenesis.
    Qi X; Yuan Y; Xu K; Zhong H; Zhang Z; Zhai H; Guan G; Yu G
    PLoS One; 2015; 10(5):e0125323. PubMed ID: 25944736
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiogenic peptides improve blood flow and promote capillary growth in a diabetic and ischaemic mouse model.
    Raiter A; Bechor Z; Kleiman M; Leshem-Lev D; Battler A; Hardy B
    Eur J Vasc Endovasc Surg; 2010 Sep; 40(3):381-8. PubMed ID: 20226697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of myeloperoxidase increases revascularization and improves blood flow in a diabetic mouse model of hindlimb ischaemia.
    Weihrauch D; Martin DP; Jones D; Krolikowski J; Struve J; Naylor S; Pritchard KA
    Diab Vasc Dis Res; 2020; 17(3):1479164120907971. PubMed ID: 32223319
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of fragmin/protamine microparticles containing fibroblast growth factor-2 (F/P MPs/FGF-2) to induce collateral vessels in a rabbit model of hindlimb ischemia.
    Horio T; Fujita M; Tanaka Y; Ishihara M; Kishimoto S; Nakamura S; Hase K; Maehara T
    J Vasc Surg; 2011 Sep; 54(3):791-8. PubMed ID: 21620612
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metformin stimulates ischemia-induced revascularization through an eNOS dependent pathway in the ischemic hindlimb mice model.
    Takahashi N; Shibata R; Ouchi N; Sugimoto M; Murohara T; Komori K
    J Vasc Surg; 2015 Feb; 61(2):489-96. PubMed ID: 24993950
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.